A growing number of people with stage 4 cancer are experiencing the power of this new medication. “It does provide options ...

An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown ...

The signs of pancreatic cancer are very subtle and often overlooked. Dr Sethi shares seven things to look out for to detect ...

Targeted compound daraxonrasib successfully blocks multiple KRAS variants to double survival limits in clinical trials.

Navigating a cancer diagnosis often begins with a simple online search. The new Cancer Search Bar series from CURE brings those commonly searched questions directly to oncology ex ...